Neuromuscular Blocking Actions of Hexamethonium, Rocuronium and (-)Vesamicol
暂无分享,去创建一个
[1] O. Larsson,et al. Distinct Pharmacologic Properties of Neuromuscular Blocking Agents on Human Neuronal Nicotinic Acetylcholine Receptors: A Possible Explanation for the Train-of-four Fade , 2006, Anesthesiology.
[2] H. Kilbinger,et al. Presynaptic nicotine receptors mediating a positive feed-back on transmitter release from the rat phrenic nerve , 1986, Naunyn-Schmiedeberg's Archives of Pharmacology.
[3] H. Kilbinger,et al. Release of [3H]acetylcholine from a modified rat phrenic nerve-hemidiaphragm preparation , 1986, Naunyn-Schmiedeberg's Archives of Pharmacology.
[4] Y. Adachi,et al. Presynaptic inhibitory effects of rocuronium and SZ1677 on [ 3 H ]acetylcholine release from the mouse hemidiaphragm preparation , 2002, Neurochemistry International.
[5] R. Parsons,et al. Empty synaptic vesicles recycle and undergo exocytosis at vesamicol-treated motor nerve terminals. , 1999, Journal of neurophysiology.
[6] A. England,et al. The Effect of Rate of Stimulation on Force of Contraction in a Partially Paralyzed Rat Phrenic Nerve Hemidiaphragm Preparation , 1997, Anesthesia and analgesia.
[7] S. Parsons,et al. The pharmacology of vesamicol: an inhibitor of the vesicular acetylcholine transporter. , 1992, General pharmacology.
[8] S. Bevan,et al. Modes of hexamethonium action on acetylcholine receptor channels in frog skeletal muscle , 1991, British journal of pharmacology.
[9] T. Searl,et al. The effects ofl-vesamicol, an inhibitor of vesicular acetylcholine uptake, on two populations of miniature endplate currents at the snake neuromuscular junction , 1990, Neuroscience.
[10] M. Gallacci,et al. Mechanisms of hexamethonium-induced tetanic fade in the isolated rat muscle. , 1990, Archives internationales de pharmacodynamie et de therapie.
[11] M. Rk,et al. Tetanic fade following administration of nondepolarizing neuromuscular blocking drugs. , 1989 .
[12] S.J. Hong,et al. Reversals of the neostigmine‐induced tetanic fade and endplate potential run‐down with respect to the autoregulation of transmitter release , 1988, British journal of pharmacology.
[13] Enomoto Koh-ichi. Post- and presynaptic effects of vesamicol (AH5183) on the frog neuromuscular junction. , 1988 .
[14] S. Hong,et al. Dissociation of the end-plate potential run-down and the tetanic fade from the postsynaptic inhibition of acetylcholine receptor by α-neurotoxins , 1987, Experimental Neurology.
[15] A. Gibb,et al. Nicotinic antagonists produce differing amounts of tetanic fade in the isolated diaphragm of the rat , 1986, British journal of pharmacology.
[16] S.J. Hong,et al. Mechanisms of the inhibition by neostigmine of tetanic contraction in the mouse diaphragm , 1986, British journal of pharmacology.
[17] R. Micheroli,et al. On the neurotrophic control of acetylcholine receptors at frog end‐plates reinnervated by the vagus nerve. , 1985, The Journal of physiology.
[18] R. M. Jones,et al. Factors affecting train-of-four fade. , 1985, British journal of anaesthesia.
[19] J. Byrne,et al. Effects of hexamethonium and decamethonium on end-plate current parameters. , 1981, Molecular pharmacology.
[20] W. Bowman. Prejunctional and Postjunctional Cholinoceptors at the Neuromusclar Junction , 1980, Anesthesia and analgesia.
[21] A. Harvey,et al. Antibiotic-induced Paralysis of the Mouse Phrenic Nerve–Hemidiaphragm Preparation, and Reversibility by Calcium and by Neostigmine , 1978, Anesthesiology.
[22] Corrado Ap,et al. Competitive antagonism between calcium and antibiotics at the neuromuscular junction. , 1978 .
[23] W. Bowman,et al. TETANIC FADE DURING PARTIAL TRANSMISSION FAILURE PRODUCED BY NON‐DEPOLARIZING NEUROMUSCULAR BLOCKING DRUGS IN THE CAT , 1976, Clinical and experimental pharmacology & physiology.
[24] C. Ferry,et al. An anti‐curare effect of hexamethonium at the mammalian neuromuscular junction , 1973, British Journal of Pharmacology.
[25] L. Blaber,et al. The prejunctional actions of some non‐depolarizing blocking drugs , 1973, British journal of pharmacology.
[26] G. P. Levy,et al. The neuromuscular blocking action of 2-(4-phenylpiperidino) cyclohexanol (AH 5183). , 1969, European journal of pharmacology.